Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

SB 1495 amends Tennessee law to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies the attorney general may release from pending or future opioid-related claims. The bill updates Tennessee Code Annotated Sections 20-13-203 and 33-11-103(p) to replace "Purdue Pharma L.P." with a combined list including those three new companies. This change directly affects these pharmaceutical companies by expanding the pool eligible for potential release from opioid litigation claims. The policy change modifies the legal criteria for when the state attorney general can release companies from liability in opioid cases.